Cite

HARVARD Citation

    Cemerski, S. et al. (2015). T cell activation and anti-tumor efficacy of anti-LAG-3 antibodies is independent of LAG-3 – MHCII blocking capacity. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online]. 
  
Back to record